Cite
MLA Citation
Moshe Levy et al.. “Comparison of incidence/occurrence of cardiovascular events between ponatinib vs bosutinib among patients with at least one prior line of tyrosine kinase inhibitors in chronic myeloid leukemia in a community setting in the United States.” Cancer treatment and research communications, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100139921362.0x000004